Lv Q - Search Results

1

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.

Zhang Z, Shen X, Tan Z, Mei Y, Lu T, Ji Y, Cheng S, Xu Y, Wang Z, Liu X, He W, Chen Z, Chen S, Lv Q. Zhang Z, et al. Among authors: lv q. Front Genet. 2023 Jan 13;13:1053263. doi: 10.3389/fgene.2022.1053263. eCollection 2022. Front Genet. 2023. PMID: 36712869 Free PMC article.

2

Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma.

Mei Y, Lv Q, Tan Z, Zhang Z, Ji Y, Chen S, Shen X. Mei Y, et al. Among authors: lv q. Biotechnol Genet Eng Rev. 2023 May 16:1-22. doi: 10.1080/02648725.2023.2209409. Online ahead of print. Biotechnol Genet Eng Rev. 2023. PMID: 37191010

3

Correction to: Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.

Yu K, Yang H, Lv QL, Wang LC, Tan ZL, Zhang Z, Ji YL, Lin QX, Chen JJ, He W, Chen Z, Shen XL. Yu K, et al. Cancer Cell Int. 2023 Aug 29;23(1):183. doi: 10.1186/s12935-023-03035-0. Cancer Cell Int. 2023. PMID: 37644494 Free PMC article. No abstract available.

4

Bacoside a inhibits the growth of glioma by promoting apoptosis and autophagy in U251 and U87 cells.

Liu HY, Ji YL, Du H, Chen SH, Wang DP, Lv QL. Liu HY, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2105-2120. doi: 10.1007/s00210-023-02724-x. Epub 2023 Oct 2. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37782380

5

Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas.

Ji YL, Kang K, Lv QL, Wang DP. Ji YL, et al. Mini Rev Med Chem. 2023 Oct 6. doi: 10.2174/0113895575253875230922055711. Online ahead of print. Mini Rev Med Chem. 2023. PMID: 37859309

6

Nutritional Status and Incidence of Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy.

Guan C, Lu T, Liao Z, Rich E, Gong X, Lv Q, Li J. Guan C, et al. Among authors: lv q. Nutr Cancer. 2024;76(2):196-206. doi: 10.1080/01635581.2023.2294523. Epub 2024 Jan 18. Nutr Cancer. 2024. PMID: 38113055

7

Progress of engineered bacteria for tumour therapy.

Xia X, Zhang JW, Zhao B, Zhang M, Chen ZR, Zhang BF, Ji YL, Wang X, Xiong WM, Li JW, Lv QL. Xia X, et al. Int Immunopharmacol. 2024 May 10;132:111935. doi: 10.1016/j.intimp.2024.111935. Epub 2024 Apr 9. Int Immunopharmacol. 2024. PMID: 38599096 Review.

8

Novel quinazoline-based dual EGFR/c-Met inhibitors overcoming drug resistance for the treatment of NSCLC: Design, synthesis and anti-tumor activity.

Zhang H, Gan W, Fan D, Zheng P, Lv Q, Pan Q, Zhu W. Zhang H, et al. Among authors: lv q. Bioorg Chem. 2024 Jan;142:106938. doi: 10.1016/j.bioorg.2023.106938. Epub 2023 Oct 27. Bioorg Chem. 2024. PMID: 37913585

9

Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.

Ying J, Huang Y, Ye X, Zhang Y, Yao Q, Wang J, Yang X, Yu C, Guo Y, Zhang X, Lv Q, Wang C, Mao W, Zhao A. Ying J, et al. Among authors: lv q. Int Immunopharmacol. 2024 Jan 5;126:111205. doi: 10.1016/j.intimp.2023.111205. Epub 2023 Nov 29. Int Immunopharmacol. 2024. PMID: 38029550

10

URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation.

Wang DP, Kang K, Sun J, Lin Q, Lv QL, Hai J. Wang DP, et al. Among authors: lv ql. Oxid Med Cell Longev. 2022 May 12;2022:4139330. doi: 10.1155/2022/4139330. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35602108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,529 results

Search Page